Baldwin Susan L, Powell Tim D, Wonderling Ramani S, Keiser Katherine C L, Morales Tony, Hunter Shirley, McDermott Martin, Radecki Steven V, Milhausen Michael J
Biologics Division, Heska Corporation, 1613 Prospect Pkwy, Fort Collins, CO 80525, USA.
Am J Vet Res. 2003 Dec;64(12):1465-71. doi: 10.2460/ajvr.2003.64.1465.
To use transient and stable transfection of Chinese hamster ovary cells to clone the gene encoding feline erythropoietin (feEPO) protein, characterize the expressed protein, and assess its biological activity.
Cultures of Chinese hamster ovary or TF-1 cells.
The gene encoding feEPO was cloned into a eukaryotic expression plasmid. Chinese hamster ovary cells were transiently or stably transfected with the plasmid. Expressed recombinant feEPO (rfeEPO) protein was purified from transiently transfected cells. The protein was characterized by use of SDS gel electrophoresis and western blot analysis. Biological activity was assessed by measuring thymidine incorporation by TF-1 erythroleukemic cells.
Purified rfeEPO from supernatants of transiently transfected cells was determined to be 34 to 40 kilodaltons (kd) by use of SDS gel electrophoresis, whereas the molecular weight predicted from the amino acid sequence was 21.5 kd. The banding pattern and high molecular weight suggested the protein was glycosylated. The rfeEPO proteins derived from transient or stable transfections subsequently were determined to be biologically active in vitro.
The gene encoding feEPO can be transfected into eukaryotic cells, and the expressed rfeEPO protein is biologically active in vitro. Cats with chronic renal failure often are anemic as a result of reduced expression of erythropoietin (EPO). Treatment with human-derived EPO stimulates RBCs in anemic cats; however, treatment is often limited by the development of antibodies directed against the recombinant human protein, which can then cross-react with endogenous feEPO. Recombinant feEPO may prove beneficial for use in cats with chronic renal failure.
利用中国仓鼠卵巢细胞的瞬时转染和稳定转染来克隆编码猫促红细胞生成素(feEPO)蛋白的基因,对表达的蛋白进行表征,并评估其生物学活性。
中国仓鼠卵巢细胞或TF-1细胞培养物。
将编码feEPO的基因克隆到真核表达质粒中。用该质粒对中国仓鼠卵巢细胞进行瞬时或稳定转染。从瞬时转染的细胞中纯化表达的重组feEPO(rfeEPO)蛋白。通过十二烷基硫酸钠凝胶电泳和蛋白质印迹分析对该蛋白进行表征。通过测量TF-1红白血病细胞的胸苷掺入来评估生物学活性。
利用十二烷基硫酸钠凝胶电泳测定,从瞬时转染细胞的上清液中纯化的rfeEPO为34至40千道尔顿(kd),而根据氨基酸序列预测的分子量为21.5 kd。条带模式和高分子量表明该蛋白被糖基化。随后确定源自瞬时或稳定转染的rfeEPO蛋白在体外具有生物学活性。
编码feEPO的基因可转染到真核细胞中,表达的rfeEPO蛋白在体外具有生物学活性。患有慢性肾衰竭的猫通常因促红细胞生成素(EPO)表达降低而贫血。用人源EPO治疗可刺激贫血猫的红细胞生成;然而,治疗常常受到针对重组人蛋白的抗体产生的限制,这些抗体随后可与内源性feEPO发生交叉反应。重组feEPO可能被证明对患有慢性肾衰竭的猫有益。